The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin

REL-1017 (esmethadone) is a novel N-methyl-D-aspartate receptor (NMDAR) antagonist and promising rapid antidepressant candidate. Using fluorometric imaging plate reader (FLIPR) assays, we studied the effects of quinolinic acid (QA) and gentamicin, with or without L-glutamate and REL-1017, on intrace...

Полное описание

Библиографические подробности

Главные авторы:	Ezio Bettini, Sara De Martin, Andrea Mattarei, Marco Pappagallo, Stephen M. Stahl, Francesco Bifari, Charles E. Inturrisi, Franco Folli, Sergio Traversa, Paolo L. Manfredi
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2022-07-01
Серии:	Pharmaceuticals
Предметы:	COVID-19 esmethadone gentamicin major depressive disorder (MDD) neuropsychiatric N-methyl-D-aspartate receptor
Online-ссылка:	https://www.mdpi.com/1424-8247/15/7/882
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!